Metropolis molecular genomics study shows genetic profiling are improving survival rates: Our Bureau, Bengaluru Friday, November 22, 2024, 14:45 Hrs [IST] Metropolis Healthcare co ...

Gastrointestinal (GI) cancers are among the most common cancer types affecting millions worldwide with a poor survival rate ...

Advances in molecular diagnostics, particularly Next Generation Sequencing (NGS), have revolutionized the field of oncology.

A defining feature of many cancers is genomic instability, which refers to the increased likelihood of acquiring mutations during cell division. These alterations can serve as potential biomarkers for ...

A groundbreaking approach slows tumor growth while boosting the immune system’s defense against cancer cells. Prostate cancer ranks as the second most common cancer among men globally. Despite recent ...

Fighting bowel cancer with the bacteria Salmonella could be a step closer thanks to a new discovery by researchers at the ...

Researchers at Saint Louis University's School of Medicine say T-cell dysfunction is leading to an increased risk of cancer ...

Molecular Partners said it expanded an agreement with Orano Med to develop and market Radio-DARPin therapeutics for the treatment of cancer. The biotechnology company said the new agreement will ...

(NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer ... AACR Symposium on Molecular Targets and ...